No profile data available.
NanoViricides, Inc. (NNVC) is a healthcare company in the antiviral pharmaceuticals industry, based in Shelton, United States, with about 7 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$9.47 million. In Q4 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $33.18 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2025; market data as of October 9, 2026.
, a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections.
NanoViricides reported $0 in revenue for fiscal year 2025. In Q4 2026 revenue was $0.
$33.18 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antiviral pharmaceuticals) include Kalaris Therapeutics, Inc. (KLRS), Tevogen Bio Holdings Inc. (TVGN), Serina Therapeutics, Inc. (SER), Cocrystal Pharma, Inc. (COCP).